• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Glooko picks up security certification for diabetes patient management platform

February 6, 2023 By Sean Whooley

Glooko LogoGlooko announced today that it received ISO 27001 certification for its data management and remote patient monitoring platforms.

Palo Alto, California-based Glooko develops remote patient monitoring and chronic care management products. These include data management technologies for insulin delivery devices.

ISO 27001, an international compliance framework, serves as the international security standard for protecting customer information. Compliance confirms that Glooko offers a comprehensive security management program and follows gold-standard practices, according to a news release.

“Achieving this internationally recognized standard is evidence of Glooko’s commitment to best-in-class business processes and security operations,” said Glooko CEO Russ Johannesson. “This certification enables us to demonstrate to our current and future customers that we take the protection of health data seriously.”

SGS-TÜV Saar served as Glooko’s independent, third-party ISO 27001 auditor. The certification ensures that Glooko has all required controls in place to ensure the security of customer data and its software platforms.

The company said that achieving ISO 27001 allows it to assure customers that patient health data remains secure from unauthorized access or compromise.

“This certification allows Glooko to meet compliance expectations for customers and partners who are looking for independent assurance of our security practices,” said Prakash Menon, Glooko CTO. “After going through a 12-month implementation and auditing process, we’ve fully implemented all ISO 27001 processes and controls. Customers should expect this level of commitment from any vendor that handles their data and we are happy to be able to provide this assurance to them.”

Filed Under: Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: glooko

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS